OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19
Alberto Alape‐Girón, Andrés Moreira‐Soto, Mauricio Arguedas, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 11
Alberto Alape‐Girón, Andrés Moreira‐Soto, Mauricio Arguedas, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 11
Showing 11 citing articles:
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 51
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 51
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand
Nicola Zambrano, Guendalina Froechlich, Dejan Lazarević, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1325-1325
Open Access | Times Cited: 20
Nicola Zambrano, Guendalina Froechlich, Dejan Lazarević, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1325-1325
Open Access | Times Cited: 20
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study
Sammy Huygens, Tim Preijers, Francis Swaneveld, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 4, pp. 497-509
Open Access | Times Cited: 3
Sammy Huygens, Tim Preijers, Francis Swaneveld, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 4, pp. 497-509
Open Access | Times Cited: 3
Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19
Viviane Fongaro Botosso, Soraia Attie Calil Jorge, Renato Mancini Astray, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Viviane Fongaro Botosso, Soraia Attie Calil Jorge, Renato Mancini Astray, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Immunogenic fusion proteins induce neutralizing SARS-CoV-2 antibodies in the serum and milk of sheep
Gregory M. Jacobson, Kirsty Kraakman, Olivia Wallace, et al.
Biotechnology Reports (2023) Vol. 38, pp. e00791-e00791
Open Access | Times Cited: 4
Gregory M. Jacobson, Kirsty Kraakman, Olivia Wallace, et al.
Biotechnology Reports (2023) Vol. 38, pp. e00791-e00791
Open Access | Times Cited: 4
Using in vivo animal models for studying SARS-CoV-2
Camila Braz Pereira da Costa, Ana Claudia de Menezes Cruz, Julio Cesar Q Penha, et al.
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 2, pp. 121-137
Open Access | Times Cited: 6
Camila Braz Pereira da Costa, Ana Claudia de Menezes Cruz, Julio Cesar Q Penha, et al.
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 2, pp. 121-137
Open Access | Times Cited: 6
Equine immunoglobulin fragment F(ab’)2 displays high neutralizing capability against multiple SARS-CoV-2 variants
Divya Gupta, Farhan Ahmed, Dixit Tandel, et al.
Clinical Immunology (2022) Vol. 237, pp. 108981-108981
Open Access | Times Cited: 4
Divya Gupta, Farhan Ahmed, Dixit Tandel, et al.
Clinical Immunology (2022) Vol. 237, pp. 108981-108981
Open Access | Times Cited: 4
Development of Polyclonal Chicken Egg Yolk Immunoglobulin Y (IgY) Antibodies Targeting SARS-CoV-2 Multi-Epitope Antigen
Azzania Fibriani, Katerina Naisanu, Nicholas Yamahoki, et al.
Journal of Virological Methods (2024) Vol. 331, pp. 115062-115062
Closed Access
Azzania Fibriani, Katerina Naisanu, Nicholas Yamahoki, et al.
Journal of Virological Methods (2024) Vol. 331, pp. 115062-115062
Closed Access
Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulins: a phase I/II dose finding study
Sammy Huygens, Tim Preijers, Francis Swaneveld, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Sammy Huygens, Tim Preijers, Francis Swaneveld, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design
Rima Moghnieh, Dania Abdallah, Mohamed H. Sayegh, et al.
Vaccine (2022) Vol. 40, Iss. 30, pp. 3987-3988
Open Access | Times Cited: 1
Rima Moghnieh, Dania Abdallah, Mohamed H. Sayegh, et al.
Vaccine (2022) Vol. 40, Iss. 30, pp. 3987-3988
Open Access | Times Cited: 1
Immunogenic fusion proteins induce neutralizing SARS-CoV-2 antibodies in the serum and milk of sheep
Gregory M. Jacobson, Kirsty Kraakman, Olivia Wallace, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Gregory M. Jacobson, Kirsty Kraakman, Olivia Wallace, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
